Work

Alogliptin, a potent and selective dipeptidyl peptidase-IV inhibitor for the treatment of type 2 diabetes.

Year: 2008

Type: article

Source: PubMed

Author: Carolyn F Deacon

Institution: University of Copenhagen

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W86081567

FWCI: 4.114

Cites:

Cited by: 37

Related to: 10